Exocrine Pancreatic Insufficiency (EPI) Market Size & Share Report, 2030

Global Exocrine Pancreatic Insufficiency (EPI) Market Research Report: Forecast (2024-2030)

Exocrine Pancreatic Insufficiency Market Report - By Treatment Method (Pancreatic Exocrine Replacement Therapies (PERT), Nutritional Therapy), By Distribution Channel (Hospital Pharmacies, Retail Phar... ... rmacies, Retail Pharmacies, Online Pharmacies), Others Read more

Healthcare
May 2024
Pages 196
Report Format: PDF, Excel, PPT

Market Definition

Treatment primarily given to patients suffering from Exocrine pancreatic insufficiency (EPI) & experiencing symptoms such as difficulties in digesting and absorbing nutrients from food. These treatment techniques often involve enzyme replacement therapy to aid digestion, improve nutrient absorption, and optimize nutritional intake.

Market Insights & Analysis: Global Exocrine Pancreatic Insufficiency (EPI) Market (2024-30):

The Global Exocrine Pancreatic Insufficiency (EPI) Market is estimated to grow at a CAGR of around 7.2% during the forecast period, i.e., 2024-30. The factors contributing to a surge in the demand for therapies are the growing awareness about these updated therapies among healthcare professionals and the growth of the population dealing with pancreatic ailments.

Report Coverage	Details
Study Period	Historical Data: 2019-22
	Base Year: 2023
	Forecast Period: 2024-30
CAGR (2024-2030)	7.2%
Regions Covered	North America: The US, Canada, Mexico
	South America: Brazil, Rest of South America
	Europe: Germany, The UK, France, Italy, Spain, Rest of Europe
	Asia-Pacific: China, Japan, India, South Korea, Australia, Rest of Asia-Pacific
	Middle East & Africa: GCC, South Africa, Rest of Middle East & Africa
Key Companies Profiled	AbbVie Inc ., Nestlé, Digestive Care, Inc., Alcresta Therapeutics, Inc., Organon Group of Companies, Vivus LLC, and Others
Unit Denominations	USD Million/Billion

Further, the presence of a large number of overweight and obese individuals worldwide has positively influenced the Exocrine Pancreatic Insufficiency (EPI) Market. For instance, as per the World Health Organization (WHO), in 2022, around 2.5 billion adults were overweight and approximately 890 million people were living with obesity.

The inhabitants with obesity & weight problems have been linked to a lack of endocrine and other pancreatic disorders. Hence, with such a high preponderance of obesity, the risk for an exocrine pancreatic shortage has expanded. It has led consumers to go through a proper diagnosis and treatment, either through nutritional therapy or PERT. As a result, the Global Exocrine Pancreatic Insufficiency (EPI) Market has been recording growth.

Also, individuals & nations across the globe are glimpsing economic growth due to which there has been a swell in healthcare spending. This rise in healthcare expenses worldwide is leading to more additional aid allotment at health centers for providing high-quality diagnosis, treatment, and administration of chronic conditions. Therefore, individuals dealing with these issues are benefiting from healthcare services and treatments quickly, thereby driving market growth.

Market Segmentation
Introduction
1. Product Definition
2. Research Process
3. Assumptions
Executive Summary
Global Exocrine Pancreatic Insufficiency Market Trends & Developments
Global Exocrine Pancreatic Insufficiency Market Dynamics
1. Drivers
2. Challenges
Global Exocrine Pancreatic Insufficiency Market Hotspot & Opportunities
Global Exocrine Pancreatic Insufficiency Market Regulations & Policy
Global Exocrine Pancreatic Insufficiency Market Clinical Trials Landscape
Global Exocrine Pancreatic Insufficiency Market Outlook, 2019-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Size & Analysis
  1. By Treatment Method
    1. Pancreatic Exocrine Replacement Therapies (PERT)- Market Size & Forecast 2019-2030, USD Million
    2. Nutritional Therapy- Market Size & Forecast 2019-2030, USD Million
  2. By Distribution Channel
    1. Hospital Pharmacies- Market Size & Forecast 2019-2030, USD Million
    2. Retail Pharmacies- Market Size & Forecast 2019-2030, USD Million
    3. Online Pharmacies- Market Size & Forecast 2019-2030, USD Million
  3. By Region
    1. North America
    2. South America
    3. Europe
    4. The Middle East & Africa
    5. Asia-Pacific
  4. By Competition
    1. Competition Characteristics
    2. Market Share of Companies
North America Exocrine Pancreatic Insufficiency Market Outlook, 2019-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Treatment Method- Market Size & Forecast 2019-2030, USD Million
  2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
  3. By Country
    1. The US
    2. Canada
    3. Mexico
3. The US Exocrine Pancreatic Insufficiency Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Treatment Method- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
4. Canada Exocrine Pancreatic Insufficiency Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Treatment Method- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
5. Mexico Exocrine Pancreatic Insufficiency Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Treatment Method- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
South America Exocrine Pancreatic Insufficiency Market Outlook, 2019-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Treatment Method- Market Size & Forecast 2019-2030, USD Million
  2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
  3. By Country
    1. Brazil
    2. Rest of South America
3. Brazil Exocrine Pancreatic Insufficiency Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Treatment Method- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
Europe Exocrine Pancreatic Insufficiency Market Outlook, 2019-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Treatment Method Market Size & Forecast 2019-2030, USD Million
  2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
  3. By Country
    1. Germany
    2. The UK
    3. France
    4. Spain
    5. Italy
    6. Rest of Europe
3. Germany Exocrine Pancreatic Insufficiency Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Treatment Method- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
4. The UK Exocrine Pancreatic Insufficiency Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Treatment Method- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
5. France Exocrine Pancreatic Insufficiency Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Treatment Method- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
6. Spain Exocrine Pancreatic Insufficiency Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Treatment Method- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
7. Italy Exocrine Pancreatic Insufficiency Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Treatment Method- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
The Middle East & Africa Exocrine Pancreatic Insufficiency Market Outlook, 2019-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Treatment Method- Market Size & Forecast 2019-2030, USD Million
  2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
  3. By Country
    1. GCC
    2. South Africa
    3. Rest of the Middle East & Africa
3. GCC Exocrine Pancreatic Insufficiency Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Treatment Method- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
4. South Africa Exocrine Pancreatic Insufficiency Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Treatment Method- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
Asia-Pacific Exocrine Pancreatic Insufficiency Market Outlook, 2019-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Treatment Method - Market Size & Forecast 2019-2030, USD Million
  2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
  3. By Country
    1. China
    2. Japan
    3. Australia
    4. South Korea
    5. India
    6. Rest of Asia-Pacific
3. China Exocrine Pancreatic Insufficiency Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Treatment Method- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
4. Japan Exocrine Pancreatic Insufficiency Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Treatment Method- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
5. Australia Exocrine Pancreatic Insufficiency Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Treatment Method- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
6. South Korea Exocrine Pancreatic Insufficiency Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Treatment Method- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
7. India Exocrine Pancreatic Insufficiency Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Treatment Method- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
Global Exocrine Pancreatic Insufficiency Market Key Strategic Imperatives for Growth & Success
Competitive Outlook
1. Company Profiles
  1. AbbVie Inc.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  2. Nestlé S.A.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  3. Digestive Care, Inc.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  4. Alcresta Therapeutics, Inc.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  5. Organon Group of Companies
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  6. Vivus, LLC
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  7. Others
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

Full Name*:

Company Name*:

Business Email*:

Country Name*:

Contact Number*:

Message:

Flexible Licensing Options

We offer flexible licensing options to cater to varying organizational needs. Choose the pricing pack that best suits your requirements:

Buy Now

Inquire Before Buying